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Plantscontainpotentiallytoxiccompoundsforanimalsandanimalshavedevelopedphysiologicalstrategiestodetoxifytheingested
toxins during evolution. Feeding mice with various plant seeds and grains showed unexpected result that only sesame killed
PPARα-null mice but not wild-type mice at all. A detailed analysis of this observation revealed that PPARα is involved in the
metabolism of toxic compounds from plants as well as endobiotic substrates by inducing phase I and phase II detoxiﬁcation
enzymes. PPARα plays a vital role in direct or indirect activation of the relevant genes via the complex network among other
xenobiotic nuclear receptors. Thus, PPARα plays its wider and more extensive role in energy metabolism from natural food intake
to fat storage than previously thought.
1.Introduction
Animals feed on plants for nutritional and tasting reasons.
Plants and seeds are important energy sources but they
also contain unique compounds and a variety of secondary
metabolites some of which are potentially toxic to animals
[1]. Chlorophyll, for example, is a green pigment essential
for conversion of the energy of sunlight into chemical energy
but its derivative contains a branched fatty acid, phytanic
acid, which is toxic at least for rodents and human. Popular
plant toxins include ﬂavonoids, isoﬂavonoids, and tannins,
but there should be much more. Animals have developed
physiological strategies to avoid speciﬁc plants and to
detoxify the ingested toxins. Physiological detoxiﬁcation can
occurinthemouthandthegutrumenwithorwithoutahelp
of microbes and once absorbed toxins must be detoxiﬁed
in the intestine and liver [2]. Phytanic acid is completely
brokendown intheliverand afattyaldehydedehydrogenase,
FALDH encoded by ALDH3A2,playsakeyroleintheprocess
[3–5] as its defect causes Sj¨ ogren-Larsson syndrome [6, 7].
However, identiﬁcation of potentially toxic compounds in
plants and seeds is incomplete and the mechanisms of
detoxiﬁcation steps have not been well characterized yet
because most animal studies to date have been carried out
using artiﬁcial laboratory diets. Recently, we found that a
nuclear receptor peroxisome proliferator-activated receptor
α (PPARα) plays a vital role in induction of a detoxiﬁcation
system by using natural plant seeds as diets for mice [8].
An important role of PPARα in lipid catabolism in the
liverhasbeenwellestablished[9],butthePPARα-nullmouse
shows little phenotypic change when fed with normal labo-
ratory diet [10, 11]. We searched its extrahepatic roles and
found that PPARα is essential to induce 17β-hydroxysteroid
dehydrogenase type 11 (17βHSD11) in the intestine [12].
Studiesonthesubstratespeciﬁcityof17βHSD11showedthat
it includes not only glucocorticoids and sex steroids but also
bile acids, fatty acids, and branched amino acids [13, 14]. So
we examined the possibility that PPARα p l a y sav i t a lr o l ei n
inducing enzymes for metabolizing secondary metabolites of
plants by feeding natural plant seeds. We begin this review
by summarizing our results of experiments using various
plant seeds as diets for wild-type mice and PPARα-null mice.
The main focus of this review is on the role of PPARα in
inducing a detoxiﬁcation system against potentially toxic
plant compounds.2 PPAR Research
2.All PPARα-Null Mice Died within 40 Days of
SesameDiet
Sesame is widely thought to be a healthy food and it contains
several lignans and lignan glycosides that have antioxidant
properties [15, 16]. Thus, our result that feeding the PPARα-
null mice with sesame seeds for a short period sometimes
caused the death [8] was totally unexpected for us. We ﬁrst
examined whether the lethal eﬀect of feeding sesame to
PPARα-null mice was speciﬁc to sesame, or whether similar
results could be caused by other plant seeds or nuts. For this
study,almond(Prunusdulcis)nutsandsunﬂower(Helianhus
annuus) seeds were chosen as control diets on the basis of
theirlipidcontents.Allarerichinlipids,butsesameseedsare
rich in oleic acid and linoleic acid, whereas almond nuts are
rich in oleic acid and sunﬂower seeds are rich in linoleic acid.
Only sesame seeds among the three fatty seeds killed PPARα-
null mice in several days. This result suggests that a large
amount of major fatty acids itself is not toxic for PPARα-null
micebutsomesesame-speciﬁcor-enriched compounds may
be involved in causing a lethal eﬀect in the liver. However,
major lignans and lignan glycosides in sesame seeds were not
toxic.
Feeding these seeds and nuts induced the formation of
lipid droplets with similar fatty acid compositions to those
of the diets in the liver of both wild-type and PPARα-
null mice [17]. Thus, the fatty acid compositions of neutral
lipids in hepatic lipid droplets were strongly inﬂuenced by
those in the diet, suggesting that the lipid droplets promptly
stored the diet-derived excess fats with unfavorable fatty acid
compositions and protected the cells from lipotoxicity. No
lethal eﬀect of feeding almond nuts or sunﬂower seeds to
PPARα-null mice was observed. The fatty acid compositions
of the hepatic lipids quickly returned to normal after
changing the diet to the usual one in wild-type mice. This
quick reversibility suggests that enhanced lipid metabolism
to remodel the fatty acid composition occurred around the
lipid droplets in the liver of wild-type mice. However, quick
reversibility was not observed in PPARα-null mice. These
results suggest that PPARα plays an important role in the
rapid induction of lipid-metabolizing/remodeling enzymes
according to the contents of the diet [17]. However, PPARα
may not be absolutely necessary for metabolism of major
fatty acids but vital for detoxiﬁcation of minor but sesame-
enriched abnormal fatty acid(s) or compound(s).
We next examined the survival curve of mice on sesame
diet for a long period. Feeding wild-type mice with sesame
seed diet had no eﬀect on survival for at least 3 months (not
shown) but PPARα-null mice started to die in a few days
and all died within 40 days after starting the sesame diet
(Figure 1). This drastic eﬀect was age and gender dependent;
only male PPARα-null mice of older than 14 weeks of age
died on the sesame diet. During these periods, weight gain
wasnotobserved inwild-typemiceandagradualweightloss
was seen in PPARα-null mice, indicating that living only on
sesame seeds is not healthy even for wild-type mice.
The mechanism for the striking female-speciﬁc tolerance
to the sesame diet can be similar to that reported by
Djouadi et al. [18] for explanation of the result from a
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Figure 1:SurvivalcurveofnormalandPPARα-nullmiceonsesame
diet. Male PPARα-null mice on the sesame diet were followed until
all null mice (n = 12) died. None of wild-type mice (n = 4) on
the sesame diet or the PPARα-null mice on normal diet died during
these period. Time 0 is the day of starting the experiment using age-
matched (14 weeks) mice on the sesame diet.
carnitine palmitoyltransferase1 (CPT1) inhibitor, etomoxir
experimentusingPPAR-nullmice.Etomoxirtreatmentkilled
all male PPAR-null mice almost within 24h, whereas no
female PPAR-null mice nor wild-type mice died within the
same period. They did not deﬁne the mechanism for the
gender-speciﬁc response but they speculated that estradiol-
triggered fatty acid utilization pathway is important in
hepatic lipid and glucose homeostasis. Similar eﬀects of
estradiol and also of aging were reported by Duan et al. [19]
in the expression of intestinal sterol transporters. Thus, the
estradiol-dependent pathway may play an essential role in
female-speciﬁc tolerance to the sesame diet.
3.The Sesame-Diet-InducedSevere
Hypoglycemia inPPARα-NullMice
Feeding sesame seeds caused a rapid decrease in one day in
the serum levels of glucose and in the glycogen contents in
the liver of both mice although the reduction in PPARα-
null mice was much signiﬁcant compared with wild-type
mice [12]. After the reduction, wild-type mice recovered the
serum glucose levels to normal, but the severe hypoglycemia
persisted for several days in most PPARα-null mice. Thus,
the major cause of the sesame-induced death in PPARα-null
mice during a short period would be severe hypoglycemia.
There seems to be no possibility that gluconeogenesis was
blocked in the PPARα-null mice on a sesame diet at the
transcriptional level of the key enzymes in gluconeogenesis.
Although feeding sesame seeds diﬀerently changed the
levels of mRNAs for the key enzymes in gluconeogenesis
(phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-
phosphatase (G6Pase), PPARγ-coactivator 1α (PGC-1α),
and aquaporins 3 and 9) between wild-type mice and
PPARα-null mice, these small changes could not fullyPPAR Research 3
explain the sesame-seed-induced persisting hypoglycemia
in the PPARα-null mice. Another possibility might be that
ATP supply necessary for gluconeogenesis was not enough
because mitochondrial function including β-oxidation of
fatty acids in the liver was inhibited by some compounds
from sesame seeds. The toxic compounds should have been
metabolized in a PPARα-dependent manner. In any case,
acute hypoglycemia alone cannot explain chronic eﬀect of
feeding sesame seeds on PPARα-null mice.
4.The Sesame-Diet-InducedFALDHin
the Liver of Normal Mice but Far Less in
PPARα-NullMice
Microarray analysis of PPARα-dependent sesame-induced
genes revealed that PPARα plays a vital role in inducing
various enzymes for protecting against oxidative stress
and xenobiotic metabolism in the intestine and liver [8].
Fatty aldehyde dehydogenase (FALDH or ALDH3A2) was
identiﬁed as one candidate enzyme induced in the liver for
lipid peroxidation [20]. Results from our detailed analyses
of the mechanisms for PPARα-dependent transcriptional
induction, subcellular localization [21], and protecting
against lipotoxicity [22] are summarized in Figure 2.B o t h
polyunsaturated fatty acids and branched fatty acids act
as ligands for PPARα and directly regulate expression of
FALDH via a direct repeat-1 (DR-1) site located in the
promoter region of the FALDH gene. Alternative splicing
produces two isoforms, FALDH-N and FALDH-V. FALDH-
N localizes on endoplasmic reticulum membrane and detox-
iﬁes polyunsaturated fatty-acid-derived fatty aldehydes and
protects cells from endoplasmic reticulum stress. FALDH-
V is a unique peroxisome-speciﬁc aldehyde dehydrogenase
playing an essential role in oxidation of branched fatty acids
including lipid peroxidation products and phytanic acid
from plants.
The expression levels of major endoplasmic localizing
FALDH-N and peroxisome-speciﬁc FALDH-V in wild-type
and PPARα-null mice fed normal or sesame-diet were
examined by the real-time PCR analysis using the isoform-
speciﬁc PCR primers. Both FALDH isoforms were induced
severalfoldfromthebasallevelsbyfeedingsesameregardless
of whether PPARα was expressed or not [21]. This result
indicates that expression of FALDH is also regulated by a
PPARα-independent mechanism. However, the basal expres-
sion levels of both isoforms in PPARα- n u l lm i c ew e r eq u i t e
lowandeventheirinducedlevelswerebarelysimilarwiththe
uninducedlevelsinwild-typemice.Theseresultssuggestthat
the FALDH activities in the liver of PPARα-null mice were
not high enough to protect from the oxidative stress caused
by feeding the sesame diet.
5.The Sesame DietDidNot Cause
a SigniﬁcantOxidativeStressbut Induced
HepatoxicityinPPARα-NullMice
We next directly examined the possibility that sesame-diet-
induced oxidative stress in PPARα-null mice by measuring
the serum levels of 8-hydroxy-2 -deoxyguanosine (8OH-
dG), an indicator of oxidative damage of DNA [23], and
8-isoprostane, an autooxidation product from arachidonic
acid and a biomarker for oxidative stress [24]. The levels
of 8OH-dG did not change signiﬁcantly in wild-type or
PPRα-null mice feeding normal or sesame diet. In contrast,
the levels of 8-isoprostane in the sera of PPARα-null mice
were about 3-fold higher than those of wild-type mice even
feeding normal diet (0.3–0.4 versus 0.4–1.4ng/mL) and the
sesame diet did not raise the levels signiﬁcantly. These results
indicate that the sesame diet does not induce a signiﬁcant
oxidative stress and that FALDH may not play an important
role in protecting the cells from lipotoxicity induced by the
sesame diet. However, they do not exclude a possibility that
FALDH is important for metabolism of the sesame-derived
toxic compounds.
17βHSD11 was also identiﬁed as a sesame-diet-inducible
enzyme in a PPARα-dependent manner [8]. 17βHSD11 is
mostly localized on the endoplasmic reticulum membrane
under normal conditions and redistributes to lipid droplets
when their formation is induced by a lipid-rich diet [25, 26].
Its involvement in detoxiﬁcation of lipophilic toxic com-
pounds compartmentalized in lipid droplets is a plausible
possibility. Thus, we think that FALDH and 17βHSD11 are
important for detoxiﬁcation of toxic compounds contained
in sesame seeds rather than in protecting the cells from
oxidative stress induced by a lipid-rich diet.
To assess liver damage after feeding sesame seeds, we
measured the levels of alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) in the serum of wild-type
and PPARα- n u l lm i c e[ 8]. Feeding the mice with sesame
caused hepatotoxicity as indicated by measuring the plasma
alanine transaminase (ALT) activities. At day 3 after starting
the diet, ALT activities went up from 12.5 ± 5.0( I U / L ,
±S.D.) to 26.3 ± 2.5 in wild type mice and from 13.8 ± 4.8
to 253 ± 169 in PPARα null mice, and AST also went up
from 40±7.5( I U / L ,±S.D.)to 620±220 inPPARαnullmice.
These results suggest that expression of PPARα protected the
liver cells from the damages caused by feeding sesame seeds.
6.The Sesame-Diet-InducedVariousCyps
inaPPARα-Dependent and
aPP ARα-Independent Manner
Microarray analysis was performed to identify the sesame-
diet-induceddetoxiﬁcationenzymesintheintestineandliver
by comparing the expression levels of mRNAs using RNA
isolated from wild-type mice and PPARα null mice fed with
sesameforoneweek.Sesameseeds,likeotherbotanicals[27–
29], should contain a large number of compounds that aﬀect
cell function via gene transcription or metabolic inhibition.
In addition to phase II detoxiﬁcation enzymes such as
UDP-glucuronosyltransferases (UGTs), aldoketoreductases
(AKRs), glutathione S-transferases (GSTs), and drug trans-
porters [8], the expression levels of several cytochrome P450
enzymes (Cyps) in the intestine and liver were much higher
in wild-type mice than in PPARα-null mice when they4 PPAR Research
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Figure 2: Proposed physiological role of FALDH. Polyunsaturated fatty acids or branched fatty acids bind to PPARα to express FALDH and
FALDH variants produced by alternative splicing share a role in protecting against oxidative stress in an organelle-speciﬁc manner.
fed with sesame. These Cyps were induced in a PPARα-
dependent manner as conﬁrmed by quantitative real-time
PCRanalysisalthoughsomeofthemhavenotbeenidentiﬁed
as PPARα-target genes. Expressions of the corresponding
human CYP2C9, 2B6, and 3A4 to these mouse Cyps were
reportedberegulatedbytheconstitutiveandrostanereceptor
(CAR) [30, 31]. Jackson et al. [32]p r o p o s e da ni m p e r f e c t
DR4 element as an essential element for CAR-dependent
transcriptional activation of Cyp2c29 and 2b10 genes,
although no detailed mechanism has yet been elucidated.
Thus, the indirect but essential involvement of PPARα in
the induction of these Cyps can be at the activation step of
CAR. Further analysis is clearly necessary to obtain direct
evidence of the involvement of PPARα in the activation step
of CAR. Another possibility for the indirect but essential
involvement of PPARα in the induction is that some of
them are regulated by overlapping transcriptional programs
mediatedbyanaxisofPPARα-retinoidXreceptor(RXR)and
liver X receptor (LXR) as suggested by Anderson et al. [33].
Our observations of indirect but essential involvement of
PPARα in the transcriptional activation of several Cyp genes
should provide an important clue to elucidate the activation
processes and the complex network among the xenobiotic
nuclear receptors [34–38].
Microarray analysis and quantitative real-time PCR anal-
ysis showed that most detoxiﬁcation enzyme mRNAs were
induced by the sesame diet in both the liver and intestine
and the extents of induction were larger in wild-type mice
thaninPPARα-nullmice.However,Cyp2a5wasanexception
because it was largely induced by the sesame diet in PPARα-
null mice but not all in wild-type mice (unpublished). It is
plausiblethatcertain compound(s) in sesameseeds triggered
the transcriptional activation of these Cyp genes through an
axis of nuclear receptors excluding PPARα. The reason for
the PPARα-null mouse-speciﬁc induction of some Cyps can
be explained by the mechanism that the relevant compounds
should have been metabolized to inactive form(s) in the liver
of wild-type mice in a PPARα-dependent manner.
Plant compounds
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HSDs, CYPs, UGTs, GSTs,
AKRs, ALDHs, SDRs, etc. 
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Transcriptional control
network among
Loss, repression, or inhibition
Inhibition of a speciﬁc conversion
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Figure 3: A proposed model depicting the metabolic conversion of
plant compounds in animals by the mechanism involving complex
network among the xenobiotic nuclear receptors and PPARα.
7. PPARα as a Member of Transcriptional
Regulators for Detoxiﬁcation of Unfavorable
Compounds
In conclusion, the detoxifying enzymes in the liver must
be induced by complex functional interactions among
xenobiotic receptors, such as CAR, pregnelone X receptor
(PXR), and aryl hydrocarbon receptor (AhR), to metabolize
a large number of the plant compounds that aﬀect cell
function via gene transcription, or metabolic inhibition
[8, 39, 40]. As summarized in Figure 3,P P A R α should
be one of these nuclear receptor. One receptor may be
involved in producing the metabolites/ligands for the next
receptor that will be involved in inducing the enzymes for
further metabolism. Disturbance of this network by genetic
mutation, transcriptional repression or metabolic inhibition
should severely aﬀect metabolism of xenobiotics if it goes
beyond compensating capacity coming from overlappingPPAR Research 5
functions of metabolizing enzymes. PPARα plays wider and
more extensive role in energy metabolism form catabolism
of endobiotic lipids but also for detoxiﬁcation of xenobiotic
or plant-derived unfavorable compounds than previously
thought.
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